000 01083 a2200277 4500
005 20250516060913.0
264 0 _c20140815
008 201408s 0 0 eng d
022 _a1872-7654
024 7 _a10.1016/j.ejogrb.2011.09.026
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGallos, Ioannis D
245 0 0 _aComment on: What about the relapse of endometrial hyperplasia?
_h[electronic resource]
260 _bEuropean journal of obstetrics, gynecology, and reproductive biology
_cDec 2013
300 _ae5 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aAnticarcinogenic Agents
_xadministration & dosage
650 0 4 _aDrug Delivery Systems
650 0 4 _aEndometrial Hyperplasia
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLevonorgestrel
_xadministration & dosage
700 1 _aGupta, Janesh K
773 0 _tEuropean journal of obstetrics, gynecology, and reproductive biology
_gvol. 171
_gno. 2
_gp. e5
856 4 0 _uhttps://doi.org/10.1016/j.ejogrb.2011.09.026
_zAvailable from publisher's website
999 _c21225997
_d21225997